Market cap
$475 Mln
Revenue (TTM)
$321 Mln
P/E Ratio
--
P/B Ratio
0.9
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
11014.1
-
Debt to Equity
0.4
-
Book Value
$--
-
EPS
$-0.7
-
Face value
--
-
Shares outstanding
423,037,675
10 Years Aggregate
CFO
CA$-3,004.15 Mln
EBITDA
CA$-240.05 Mln
Net Profit
CA$-7,451.42 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Canopy Growth Corp (CGC)
| -12.7 | 8.4 | -8.7 | -44.7 | -39.7 | -64.2 | -28.6 |
|
BSE Sensex*
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Canopy Growth Corp (CGC)
| -58.4 | -77.9 | -73.5 | -64.6 | 16.8 | -21.5 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Canopy Growth Corp (CGC)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company... operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada. Read more
-
CEO & Director
Mr. David Eric Klein
-
CEO & Director
Mr. Luc Mongeau
-
Headquarters
Smiths Falls, ON
-
Website
FAQs for Canopy Growth Corp (CGC)
What is the current share price of Canopy Growth Corp (CGC) Today?
The share price of Canopy Growth Corp (CGC) is $1.00 (NASDAQ) as of 31-Aug-2026 16:25 EDT. Canopy Growth Corp (CGC) has given a return of -39.75% in the last 3 years.
What is the current PB & PE ratio of Canopy Growth Corp (CGC)?
Since, TTM earnings of Canopy Growth Corp (CGC) is negative, P/E ratio is not available.
The P/B ratio of Canopy Growth Corp (CGC) is 0.91 times as on 28-Aug-2026, a 77 discount to its peers’ median range of 3.96 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
-1.39 |
0.52 |
2025 |
-0.16 |
0.20 |
2024 |
-1.18 |
1.54 |
2023 |
-0.14 |
0.63 |
2022 |
-9.64 |
0.83 |
What is the 52 Week High and Low of Canopy Growth Corp (CGC)?
The 52-week high and low of Canopy Growth Corp (CGC) are Rs 2.38 and Rs 0.84 as of 01-Sep-2026.
What is the market cap of Canopy Growth Corp (CGC)?
Canopy Growth Corp (CGC) has a market capitalisation of $ 475 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Canopy Growth Corp (CGC)?
Before investing in Canopy Growth Corp (CGC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.